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The Six1 homeobox gene plays critical roles in vertebrate organogenesis. Mice deﬁcient for Six1 show
severe defects in organs such as skeletal muscle, kidney, thymus, sensory organs and ganglia derived
from cranial placodes, and mutations in human SIX1 cause branchio-oto-renal syndrome, an autosomal
dominant developmental disorder characterized by hearing loss and branchial defects. The present
study was designed to identify enhancers responsible for the dynamic expression pattern of Six1 during
mouse embryogenesis. The results showed distinct enhancer activities of seven conserved non-coding
sequences (CNSs) retained in tetrapod Six1 loci. The activities were detected in all cranial placodes
(excluding the lens placode), dorsal root ganglia, somites, nephrogenic cord, notochord and cranial
mesoderm. The major Six1-expression domains during development were covered by the sum of
activities of these enhancers, together with the previously identiﬁed enhancer for the pre-placodal
region and foregut endoderm. Thus, the eight CNSs identiﬁed in a series of our study represent major
evolutionarily conserved enhancers responsible for the expression of Six1 in tetrapods. The results also
conﬁrmed that chick electroporation is a robust means to decipher regulatory information stored in
vertebrate genomes. Mutational analysis of the most conserved placode-speciﬁc enhancer, Six1-21,
indicated that the enhancer integrates a variety of inputs from Sox, Pax, Fox, Six, Wnt/Lef1 and basic
helix-loop-helix proteins. Positive autoregulation of Six1 is achieved through the regulation of Six
protein-binding sites. The identiﬁed Six1 enhancers provide valuable tools to understand the mechan-
ism of Six1 regulation and to manipulate gene expression in the developing embryo, particularly in the
sensory organs.
& 2012 Elsevier Inc. All rights reserved.Introduction
Six1 is a member of the homeobox gene family deﬁned by its
highly distinctive homeobox homologous to Drosophila sine oculis
(so) (Kawakami et al., 2000; Oliver et al., 1995) and its home-
odomain preferentially binds to the sequence G(A/G)TATCA over
the canonical TAAT core (Berger et al., 2008; Noyes et al., 2008).
Progress in phylogenomic analysis of basal metazoans and uni-
cellular choanoﬂagellates suggests that the ancestral Six gene
originated from a TALE class homeobox gene before the emer-
gence of metazoans (Derelle et al., 2007; Larroux et al., 2008).
A single ancestral Six gene of Six1/2 class went through gene
duplication and divergence, and gave rise to two other subfamily
genes (Six3/6 and Six4/5) after the divergence of porifera (sponges)
from other metazoans including ctenophores (Hill et al., 2010;
Hoshiyama et al., 2007; Larroux et al., 2008; Pick et al., 2010).ll rights reserved.
: þ81 285 44 5476.
mi).In metazoans, Six1 or Six1/2 subfamily genes are known for their
roles in sensory organogenesis. The founding member so is
essential for the compound eye formation in Drosophila
(Cheyette et al., 1994) and its misexpression is sufﬁcient to induce
ectopic eyes (Weasner et al., 2007). In other protostomes and
cnidarians, Six1 homologs are also known for their roles in eye
development (Arendt et al., 2002; Mannini et al., 2004; Stierwald
et al., 2004). In vertebrates, disruption of Six1 function causes
severe defects in multiple sensory organs derived from cranial
sensory placodes such as the olfactory epithelium (Chen et al.,
2009; Ikeda et al., 2010, 2007; Laclef et al., 2003b), inner ear
(Bricaud and Collazo, 2006; Kozlowski et al., 2005; Laclef et al.,
2003b; Li et al., 2003; Ozaki et al., 2004; Xu et al., 1999; Zheng
et al., 2003; Zou et al., 2004) and epibranchial ganglia (Ozaki et al.,
2004; Zheng et al., 2003; Zou et al., 2004). Six1-deﬁcient mice also
show defective development of taste papillae (Suzuki et al., 2010,
2011). Defects in the trigeminal ganglion (Konishi et al., 2006) and the
anterior pituitary (adenohypophysis), a derivative of adenohypophy-
seal placode (Li et al., 2003), were noted in Six1/Six4 and Six1/Eya1
double knockout mice, respectively. In addition, vertebrate Six1 is
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For example, Six1-deﬁcient mice show severe abnormalities in the
skeletal muscle and skeleton derived from somites (Laclef et al.,
2003a; Li et al., 2003; Ozaki et al., 2004). The kidney, salivary gland
and branchial organs such as the thymus and parathyroid gland are
also absent or severely reduced in size (Kobayashi et al., 2007; Laclef
et al., 2003b; McCoy et al., 2009; Ozaki et al., 2004; Xu et al., 2003). In
humans, mutations of SIX1 cause a severe auditory and renal disorder
known as branchio-oto-renal syndrome (Kochhar et al., 2008; Ruf
et al., 2004).
Consistent with the pleiotropic function, Six1 shows a dynamic
expression pattern, particularly in tetrapods where Six1 is
expressed in all three germ layers. In the mouse, the earliest
expression of Six1 starts in the endoderm at embryonic day 7.5
(E7.5) (Gu et al., 2004). The expression subsequently appears in
the non-neural ectoderm surrounding the anterior neural plate at
E8.0 (Sato et al., 2010). The mouse ectoderm is thought to
correspond to the pre-placodal region (PPR), previously described
in chick and amphibians, which represents a unique territory of
multipotent sensory precursor cells for all cranial placodes (Baker
and Bronner-Fraser, 2001; Brugmann and Moody, 2005; Schlosser
and Ahrens, 2004; Streit, 2002). A robust mesodermal expression
is already present at this stage. At the placodal stage (E8.5–E10.5),
Six1 expression is detected in all placodes excluding the lens
placode, pharyngeal arches and pouches, dorsal root ganglia
(DRG), somites, nephrogenic cord and notochord (Chen et al.,
2009; Laclef et al., 2003b; Oliver et al., 1995; Ozaki et al., 2004). A
recent fate-mapping study demonstrated the expression of Six1 in
the cardiogenic mesoderm as early as at E7.5, and also in cardiac
progenitors in the secondary heart ﬁeld and proepicardium
during subsequent cardiovascular development (Guo et al., 2011).
With regard to the transcriptional control of Six1 in verte-
brates, Eya1 is necessary for the expression of Six1 in several
tissues such as the otic vesicles (Xu et al., 1999), cranial ganglia
(Zou et al., 2004), and pharyngeal arches (Xu et al., 2002). Another
important observation concerning the regulation of Six1 expres-
sion is that in Six1/Six4 double knockout mice, Six1 expression was
severely reduced in the ventral otic vesicle and trigeminal
placode/ganglion (Grifone et al., 2005), suggesting that the
positive autoregulatory mechanism is important for Six1 expres-
sion in these structures. Recently, we identiﬁed a single conserved
non-coding sequence at the tetrapod Six1 loci as the rostral PPR-
speciﬁc enhancer and demonstrated the potential role of home-
odomain (Dlx5, Msx1 and Pax7) and Gata proteins in the regula-
tion (Sato et al., 2010).
The present study was designed to identify enhancers responsible
for the dynamic expression pattern of Six1, during mouse embry-
ogenesis. For this purpose, we focused on conserved non-coding
sequences (CNSs) shared among tetrapod Six1 loci. CNSs of mouse
origin were initially assessed for enhancer activity using chick
embryos. The results were conﬁrmed by mouse transgenesis, and
seven such CNSs exhibited speciﬁc enhancer activity in major Six1-
expression domains including sensory placodes. Moreover, functional
analysis of the most conserved placode enhancer (Six1-21) identiﬁed
candidates for trans-acting factors and the potential molecular basis
of the autoregulation of Six1 expression in the otic vesicle. The cis-
regulatory elements and trans-acting factors that control Six1 expres-
sion and the evolution of Six1 enhancers are discussed.Materials and methods
Animals
Mice were housed in an environmentally-controlled room in
the RIKEN CDB and in the Center for Experimental Medicine ofJichi Medical University, under the guidelines for animal experi-
ments. Fertilized eggs of chicken were purchased from Shiroyama
Poultry Farm (Kanagawa, Japan), and incubated at 38 1C in a
humidiﬁed rocking incubator. The developmental stage of chick
embryos was determined according to Hamburger and Hamilton
(1951). All animal experiments were carried out in a humane
manner after receiving approval of the Institutional Animal
Experiment Committee of the Jichi Medical University, and in
accordance with the Institutional Regulation for Animal Experi-
ment and Fundamental Guideline for Proper Conduct of Animal
Experiment and Related Activities in Academic Research Institu-
tions under the jurisdiction of the MEXT of Japan.
In situ hybridization
Whole mount in situ hybridization was performed using
single-stranded digoxigenin-UTP (Roche, Mannheim, Germany)-
labeled riboprobes as described previously (Ishihara et al., 2008a).
Hybridization was performed at 65 1C. Signals were detected with
an anti-digoxigenin antibody conjugated AP (Roche) and NBT/
BCIP (Roche) for chromogen. The plasmid harboring the full-
length chick Six1 cDNA (AB199734 in pBluescript II SKþ) was
kindly provided by Dr. Atsushi Kuroiwa, and used as a template.
Antisense RNA probe was synthesized with T3 RNA polymerase
using the HindIII-cut linearized template. After whole mount
in situ hybridization, embryos were reﬁxed with 4% paraformal-
dehyde, immersed in 18% or 30% sucrose/PBS, embedded in
optimal cutting temperature (OCT) compound (Sakura Finetek),
then frozen on dry ice, and cut into 16- to 20-mm thick sections.
Genomic sequence analysis
The genomic sequences containing Six1 and neighboring Six4
and Six6 genes were downloaded from Ensembl: Human (NCBI
36 assembly, November 2005), Mouse (NCBI m37 assembly, April
2007), Opossum (MonDom5, Oct 2006), Chicken (release 2.1, May
2006), Xenopus (assembly version 4.1, August 2005), medaka
(HdrR, Oct 2005), fugu (FUGU 4.0, Jun 2005), tetraodon (TETRA-
ODON 8.0, Mar 2007), stickleback (BROAD S1, Feb 2006) and
zebraﬁsh (Zv8, Dec 2008). Global pairwise alignment of the above
sequences were carried out using shufﬂe-LAGAN (Brudno et al.,
2003), and the results were visualized using the VISTA Browser
(Frazer et al., 2004). Direct BLAST search was also used to examine
the presence/absence of some of CNSs. Conserved transcription
factor binding sites (TFBSs) were identiﬁed using rVISTA (Loots
and Ovcharenko, 2004), Mulan (Ovcharenko et al., 2005) or TESS
(Schug, 2008). Six protein binding sequences were searched
manually using the consensus sequence TCAGGTNNC common
to all the six known Six1 target genes (Fig. 5C). The sequence
partially overlaps with the recently identiﬁed Six1 homeodo-
main-binding site G(A/G)TATCA.
Reporter plasmid and transgene construction
Reporter plasmids were constructed as described previously
for the Six1 rostral PPR enhancer, Six1-14 (Sato et al., 2010). DNA
fragments containing 14 CNSs were ampliﬁed by PCR from 200 ng
of C57BL/6 mouse genomic DNA using LA Taq DNA polymerase
(Takara, Ohtsu, Japan) or PfuTurbo DNA polymerase (Stratagene/
Agilent Technologies, Santa Clara, CA). Table S1 provides a list of
the PCR primers. The ampliﬁed fragment containing Six1-8 was
cut with HincII. The genomic DNA fragment containing Six1-17
was isolated as an NheI-SspI fragment from a Six1 genomic
subclone. The ampliﬁed and isolated DNA fragments containing
all 15 CNSs (mSix1-8 to mSix1-29) were then ligated into the
multiple cloning site of ptkEGFP vector (Uchikawa et al., 2003)
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struction of mRFP1 reporter plasmids and multimerized (2x and
4x) reporters, ptkmRFP1ver2 (Inoue et al., 2007) was used. For
construction of mutated ptkEGFP mSix1-21 reporters, LA PCR
in vitro mutagenesis system (Takara) or cassette mutagenesis
with PfuTurbo DNA polymerase, was performed using the oligo-
nucleotide primes listed in Table S2.
The DNA fragments containing CNSs were ligated into the
ASShsp68lacZpA (Sasaki and Hogan, 1996) vector for mouse
transgenesis. One of the fragments, mSix1-8, showed a highly
variable enhancer activity in transgenic mouse embryos, so
ﬂanked by insulators from the chicken b-globin locus. Two sets
of two tandem copies of the core sequence of HS4 insulator
(Recillas-Targa et al., 2002) separated by the synthetic BsmBI
(compatible with SalI ends) and BbsI (compatible with NotI ends)
restriction sites were inserted into the ClaI-BamHI sites of ASShsp-
68lacZpA, and the resultant new plasmid, ASSinsBBins, was used
to add insulators. For ASSinsBBins mSix1-8-tkintronlacZpA, the
mouse hsp68 gene promoter was replaced by the thimidine
kinase gene (tk) promoter from human herpes simplex virus
(HSV) plus the downstream synthetic intron (tkintron) from
ptkEGFP-mSix1-8. All transgenes for microinjection were excised
from ASShsp68lacZpA or ASSinsBBins vectors as SalI- or NotI-
fragments, run on an agarose gel and puriﬁed using QIAEX II gel
extraction kit (Qiagen, Hilden, Germany).
The DNA sequences of all plasmids were veriﬁed by dideoxy
sequencing and puriﬁed by QIAﬁlter Plasmid Midi Kit or EndoFree
Plasmid Maxi Kit (Qiagen). Table S3 provides a list of the plasmids
used in this study.
Electroporation into chick embryos and detection of enhancer activity
Chick embryos at stages HH4 and slightly older HH4þ were
electroporated using the CUY21 electroporator with a pair of
22 mm square platinum plates (7 v/4 mm, 50 ms pulse, 950 ms
interval, 5 pulses) and cultured on albumen-agar plate, as
described previously (Ishihara et al., 2008b; Sato et al., 2010).
For the initial screening of enhancer activity, 1.5 ml (per embryo)
of DNA solution containing 2.0–2.5 mg/ml of EGFP reporters, 0.5–
1.0 mg/ml of pCAG-HcRed (Matsuda and Cepko, 2004), and 0.01%
Fast Green in 10 mM Tris–HCl (pH 7.5) was injected in the space
between the blastoderm and vitelline membrane. pCAG-HcRed
was included to verify electroporation as it drives ubiquitous
expression of HcRed under the control of the strong CAG promo-
ter/enhancer. The embryos were examined at 24 and 48 h post-
electroporation (h.p.e.) using a stereo microscope (M205A, Leica
Microsystems, Wetzlar, Germany, or SZX16, Olympus, Tokyo,
Japan).
To determine the enhancer activity of CNSs in the DRG, DNA
solutions containing 1x reporter plasmids were injected into the
central canal of the neural tube at HH9-10 in ovo (Uchikawa et al.,
2003), and electroporated using a pair of platinum electrodes
with 0.5 mm diameter (25 v/4 mm, 50 ms pulse, 950 ms interval,
4 pulses). Embryos were examined at 6, 12 and 24 h post-
electroporation. We performed electroporation until more than
5 embryos showed homogeneous DNA distribution and normal
morphology during 48 h-culture (HH4-4þelectroporation) or 48-
h incubation (HH9-10 electroporation) periods. The patterns of
enhancer activities were highly reproducible, and essentially the
same results were obtained from those embryos. For histological
analysis, embryos were embedded in OCT compound, then frozen
on dry ice, and cut into 14-mm thick sections.
For mSix1-21 mutation analysis, mutated EGFP reporters at 2 mg/
ml (Ebox-12m, Fox-12m, Lef1-m, Pax-m1, Pax-m2, Sox-1m, Sox-12m
and Six-12m) and wild-type mRFP1 reporter at 1.6 mg/ml were co-
electroporated at HH4-4þ . The ratio of EGFP reporters to mRFP1control was kept constant (EGFP:mRFP1¼1:0.8) to adjust ﬂuores-
cence intensity, embryos were ﬁxed at 48 h.p.e. and EGFP and mRFP1
images were taken at the same exposure time from both the left and
right sides. To evaluate the effects of mutation(s), the mean values
(gray values) of the EGFP and mRFP1 channels of a ﬁxed area (about
0.20.2 mm rectangle) that covered the otic vesicle, from each side
of the embryo were measured separately. The mean EGFP levels
normalized to the mRFP1 levels were calculated, and presented
relative to the value obtained from the wild-type reporter.
Production and genotyping of transgenic mice
Transgenic mice were generated by microinjection of DNAs
into the fertilized eggs of the CD-1 (ICR) strain using a standard
protocol (Nagy et al., 2003). Transgenic embryos at E10.5 were
identiﬁed by PCR analysis of yolk sac DNA. Brieﬂy, embryos and
yolk sacs were dissected carefully in ice-cold phosphate buffered
saline (PBS), and the yolk sacs were incubated overnight at 55 1C
in 100 ml of Direct PCR Lysis Reagent (Viagen Biotech, Los Angeles,
CA) as recommended by the manufacturer. After heat-inactivation
(85 1C for 45 min), 0.2–1.0 ml of the heat-inactivated DNA solution
was subjected to PCR using a pair of primers speciﬁc to each CNS
(mSix1-8-3 to mSix1-21-1) and the adjacent mouse hsp68 pro-
moter (mhsp68) or each CNS, and the adjacent HSV tk promoter
(ptkEGFP-RP). Table S4 lists the primers used for genotyping.
X-gal staining and histological analysis of embryos
Mouse embryos at E10.5 were ﬁxed and processed for X-gal
staining as described previously (Kimura et al., 1997). The
dissected embryos were ﬁxed in 1% formaldehyde, 0.8% glutar-
aldehyde and 0.02% NP-40 in PBS for 10 min, followed by three
washes with PBS for 10 min at room temperature. Staining was
carried out 0.5–24 h at 37 1C in a solution containing 1 mg/ml
X-gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6 and 2 mM MgCl2 in PBS.
The stained embryos were washed twice with PBS and stored in
10% formaldehyde or 4% paraformaldehyde in PBS. For histologi-
cal analysis, the embryos were embedded in OCT compound, and
cut into 16-mm thick sections.
Immunoﬂuorescence examination
Immunoﬂuorescence was carried out as described previously
(Ikeda et al., 2007; Ishihara et al., 2008a). Anti-human CD57
antibody (clone HNK-1) (mouse IgM, 1:200 dilution, Becton-
Dickinson) was used to stain migrating neural crest cells. Anti-
Pax3 mouse monoclonal antibody from Developmental Hybri-
doma Bank, University of Iowa, was used to stain the trigeminal
placodes. The secondary antibodies were Alexa Fluor 633 anti-
mouse IgG (Molecular Probes/Invitrogen, Carlsbad, CA). DAPI (4,6-
diamidino-2-phenylindole, Sigma, St. Louis, MO) was used for
nuclear staining. Images of immunoﬂuorescence samples were
obtained with a microscope (BX51, Olympus, or DM5000B, Leica
Microsystems).Results
Six1 expression pattern is largely conserved in vertebrates
In the chick, previous studies have shown the expression of
Six1 in the PPR and underlying mesoderm and endoderm at stages
HH5-8, otic vesicle at about HH16, and myotomes, migrating limb
muscle myoblasts and posterior limb mesenchyme at HH20
(Heanue et al., 1999; Litsiou et al., 2005), and cranial mesenchyme
and trigeminal ganglion at HH19/20 (Mootoosamy and Dietrich,
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from the PPR and sensory organs, such as the olfactory epithe-
lium, remains unclear. Thus, in order to characterize the expres-
sion pattern of chick Six1 and to examine whether the pattern is
conserved between chick and other vertebrates, particularly
mouse, we carried out whole mount in situ hybridization using
chick embryos at stages HH5-21. At HH5 and HH7, Six1 expres-
sion was detected in the anterior part of the embryo (Fig. 1A and
B). In the ectoderm, Six1 mRNA was speciﬁc to the non-neural
domain, i.e., PPR (Streit, 2002, 2004), though it was also detected
in the underlying mesoderm and endoderm (Fig. 1A) as was
described previously (Litsiou et al., 2005; Streit, 2004). At HH8,
Six1 expression appeared in the cranial ectoderm, particularly in
the otic placode area, foregut endoderm and cranial mesenchyme
(Fig. 1C and S1B) (Seifert et al., 1993). At HH10 and HH11,Fig. 1. Expression patterns of Six1 mRNA in chick embryo examined by whole mount in
HH5 (A) and HH7 (B). Six1 expression is detected in the pre-placodal region (PPR, indic
endoderm. Dorsal view. (C) Six1 expression pattern at HH8þ . Six1 is expressed in the
somites. Dorsal view. (D, E) Six1 expression pattern at HH10 (D) and HH11 (E). Six1 ex
embryo such as the olfactory placode and somites. Dorsal view. (F, G) Six1 expression p
maxillary region, trigeminal ganglion, antero-ventral portion of the otic vesicle, epibr
somites. Lateral view. (H) Six1 expression pattern at HH21. Six1 is expressed in the he
mesenchyme of the limb buds (the pattern is similar between the forelimb and hindlim
view. At HH14 (I), Six1 is expressed only in a small number of placodal cells (I, white
stages (HH15, G) both in a cluster of cells (G, white arrow) and in the placode. At HH1
extends medially from the placode (J, indicated by a dotted line). At HH21 (H), the olfact
anterior is to the top. In F, G, I, J, anterior is to the right. In H, anterior is to the left. The p
H. ce: cranial ectoderm, ﬂ: forelimb bud, hl: hindlimb bud, oe: olfactory epithelium, ol:
epibranchial ganglia, viii: VIIIth ganglion. Scale bars: 0.5 mm, except 1 mm in H. (For in
the web version of this article.)hybridization signals became intense in the otic placode area
(Fig. 1D, E and S1C). Signals were also present in other parts of the
embryo such as the foregut endoderm, cranial mesenchyme,
ventral cranial ectoderm that give rise to future oral ectoderm
and adenohypophyseal placode, olfactory placode, somites and
notochord (Fig. 1D, E and S1C). At HH15, the hybridization signals
were detected in the ventral portion of the otic vesicle, in the
pharyngeal arches and in the maxillary region (Fig. 1F, G).
Sectioning of the stained embryo showed the presence of Six1
mRNA in the trigeminal (V) and epibranchial (VII, IX and Xth)
placodes and ganglia, pharyngeal pouch endoderm, pharyngeal
arch mesenchyme, cranial mesenchymes, Rathke’s pouch, myo-
tomes, notochord and nephrogenic cord (Fig. 1F, G, and S1D, E, F).
At HH21, Six1 expression was detected in the posterior mesench-
yme of the limb buds and dorsal root ganglia (DRGs), in additionsitu hybridization. (A, B) Six1 is expressed in the anterior region of the embryo at
ated by white arrowheads) in the ectoderm, and in the underlying mesoderm and
cranial ectoderm, including the otic placode area (indicated by dotted line) and
pression is evident in the otic placode area (dotted line), and in other parts of the
attern at HH15. Six1 is expressed in the mesenchyme in the ﬁrst pharyngeal arch,
anchial (VIIth, IXth and Xth) placodes/ganglia, pharyngeal pouch endoderm, and
ad in the structures that were positive for Six1 in the earlier stages and posterior
b buds). Lateral view. (G–J) Six1 expression in the olfactory placode area. Lateral
arrow). The hybridization signals become stronger with advanced developmental
8 (J), Six1 is expressed in the olfactory placode and a process (J, white arrow) that
ory nerve is positive for Six1 hybridization (indicated by white arrowheads). In A–E,
lanes of sections shown in Fig. S1 are indicated by the yellow dotted lines in B–D, F,
olfactory placode, ov: otic vesicle, so: somites, v- trigeminal ganglion, vii, ix and x:
terpretation of the references to color in this ﬁgure legend, the reader is reffered to
Fig. 2. Position of 16 evolutionarily conserved sequences around Six1 exons. (A, B) The VISTA plot of the 190 kb (A) and the central 26 kb (B) interval containing mouse
Six1. The plot shows conserved sequences between mouse and human, opossum, chicken, Xenopus, fugu, Tetraodon, medaka, stickleback, zebraﬁsh chromosome 20
(containing six1a) and zebraﬁsh chromosome 13 (containing six1b) (Bessarab et al., 2008). Abscissa:mouse sequence, ordinate: percentage identity in a 100 bp window. The
conserved regions above the level of 50%/100 bp are highlighted under the curve, with pink indicating conserved non-coding sequence (CNS), blue, conserved exon, and
cyan, untranslated region. Among such CNSs located in the region between the ﬂanking Six6 and Six4, 16 CNSs were conserved in mammals (mouse, human and opossum),
and chicken and/or Xenopus. They are termed Six1-8 to Six1-29 and the positions are indicated in Arabic numerals on each plot. Four CNSs (Six1-8, 10, 12 and 21) were
retained both in tetrapods and teleosts. Six1-8 of zebraﬁsh (on Chromosome 20), Six1-12 of fugu, Six1-13 of Xenopus and Six1-24 of fugu and zebraﬁsh (on Chromosome
20) are not shown in this plot. (For interpretation of the references to color in this ﬁgure legend, the reader is reffered to the web version of this article.)
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Fig. 3. Enhancer activity of 8 CNSs in electroporated chick embryos. (A) A schematic representation of the positions of CNSs harboring enhancer function. (B–G) Enhancer
activity of ptkEGFP mSix1-8. Whole mount embryo at 24 h post-electroporation (h.p.e.) (dorsal view, B) and transverse section through the trunk region (E). In the head,
EGFP expression is detected in individual cells located in the ectoderm between the lens and otic placodes (B). The otic placode (ot) is weakly positive for EGFP expression
(B). In the head, EGFP-positive cells are located both in and under (indicated by white arrowheads) the ectoderm, and most of the cells are positive for Pax3 expression
(transverse section, C), a speciﬁc marker for the trigeminal placode. In contrast, EGFP positive cells are negative for HNK-1 antigen, a speciﬁc marker for migrating neural
crest cells (D). In the trunk (E), EGFP expression was detected in somites (so). Whole mount embryo at 48 h.p.e. (HH4-4þ electroporation) (lateral view, F) showing EGFP
expression in the cranial ganglia (v, vii–x) and otic vesicle (ov). Weak expression is also observed in the posterior optic cup and brain. Whole mount embryo at 48 h.p.e.
(HH9-10 electroporation) after electroporation into the central canal of the neural tube (lateral view, G) showing EGFP expression in the dorsal root ganglia (drg) and
spinal cord (sc). (H, I) Enhancer activity of ptkEGFP mSix1-94. Whole mount embryo at 48 h.p.e. (lateral view, H) showing EGFP expression in the cranial ganglia (v and
viii) and epibranchial ectoderm (ep, marked with dotted line). Transverse section at the level of trigeminal ganglia (I). (J–M) ptkEGFP mSix1-124. Whole mount embryo
at 24 h.p.e. (J) and 48 h.p.e. (K) EGFP expression in the otic placode (ot)/vesicle (ov), the VIIIth ganglion (viii) and epibranchial ectoderm (ep). Coronal section of the head
(L) showing expression in the Rathke’s pouch (rp) and transverse section of the trunk (M) showing expression in the nephrogenic cord (nc) at 48 h.p.e. EGFP expression was
also detected in the anterior neural tube. (N–R) Enhancer activity of ptkmRFP1 mSix1-214. Whole mount embryo at 24 h.p.e. (dorsal view, N) and 48 h.p.e. (lateral view,
O), showing the expression in the olfactory (ol) placode, otic placode (ot)/vesicle (ov), the VIIIth ganglion (viii) and epibranchial ectoderm (ep). Transverse section at the
otic vesicle level (P) showing EGFP expression in the otic vesicle (ov) and epibranchial ectoderm (ep) at 48 h.p.e. Also, coronal section (Q) showing EGFP expression in the
olfactory placode (ol) and another coronal section (R) showing expression in the Rathke’s pouch (rp). (S, T) Enhancer activity of ptkmRFP1 mSix1-10. Whole mount embryo
at 24 h.p.e. (trunk region, ventral view, S) and transverse section (T) showing EGFP expression in the somites. (U–W) Enhancer activity of ptkmRFP1 mSix1-114. Whole
mount embryo at 24 h.p.e. (dorsal view, U) and transverse section (V) showing EGFP expression in the cranial mesenchyme (cm). Immunohistochemical detection of
migrating neural crest cells using HNK-1 antibody indicates EGFP-positive cells are negative for HNK-1 antigen and thus belong to cranial mesoderm (W). (X–Z) Enhancer
activity of ptkmRFP1 mSix1-17. Whole mount embryo at 24 h.p.e. (trunk region, ventral view, X) and transverse section (Y) showing EGFP expression in the notochord (no).
Weak EGFP expression is also detected in the mesodermal structures surrounding the notochord (Y), the cranial ectoderm (ce) (dorsal view, Z) and the ﬂoor plate of the
cervical neural tube (data not shown). In all panels of whole mount embryos, anterior is to the right, and all but panels S and X are dorsal views. Panels S and X are ventral
views. In all panels of whole mount embryos, the green channel (EGFP) is superimposed on each bright ﬁeld image (grayscale). In all panels of sections except panels C, D,
W, the green channel (EGFP) is superimposed on each DIC image (grayscale). DAPI is used for nuclear staining (blue in C, D, W). br: brain, ce: cranial ectoderm, cm: cranial
mesenchyme, drg: dorsal root ganglia, ep: epibranchial ectoderm, nc: nephrogenic cord, no: notochord, ol: olfactory placode, ot: otic placode, ov: otic vesicle, rp: Rathke’s
pouch, so: somites, sc: spinal cord, tg: trigeminal placode, v- trigeminal ganglion, vii, ix and x: epibranchial ganglia, viii: VIIIth ganglion. Scale bars: 0.5 mm (B, F–H, J, K, N,
O, S, U, X, Z), 0.2 mm (C–E, P, T, V, W, Y), 0.1 mm (I, L, M, Q, R). (For interpretation of the references to color in this ﬁgure legend, the reader is reffered to the web version of
this article.)
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(Fig. 1H, and S1L–N).
Overall, the above expression patterns were very similar to
those described in mouse (Laclef et al., 2003b; Li et al., 2003;
Oliver et al., 1995; Ozaki et al., 2004; Sato et al., 2010). However,
there was one intriguing exception. In the olfactory placodal
region of the chick embryo, clear hybridization signals were
observed in a small number of cells in the slightly thickened
olfactory placode at HH14 (Fig. 1I and S1G) whereas the rest of
the placodal cells were negative for such signals. With advance-
ment of embryogenesis, a cluster of cells with clear hybridization
signals were found in the underlying mesenchyme (HH15, Fig. 1G
and S1H). By HH18, the Six1-strongly positive cell clusters
changed their morphology by becoming longer, extending from
the olfactory placode (also positive for Six1 expression) toward
the forebrain on each side (Fig. 1J and S1I). This contrasts with a
strong placodal expression of Six1 and the shutdown of its
expression in cells that delaminate from the placode/epithelium
in mouse embryos (Chen et al., 2009; Ikeda et al., 2007). Finally, at
HH21, the olfactory nerves were positive for the hybridization
signals and became visible both in whole mount preparations and
sections (Fig. S1J, K). This is also different from Six1 expression
pattern in the mouse embryo.Identiﬁcation of CNSs ﬂanking Six1 exons
To identify the cis-regulatory elements that control mouse Six1
expression during embryogenesis, we ﬁrst searched for evolutionarily
CNSs surrounding Six1 exons. It has been shown that CNSs conserved
between mammals and non-mammalian tetrapods, such as chicken
and Xenopus, often possess tissue-speciﬁc enhancer activity (Gottgens
et al., 2000; Ishihara et al., 2008b; Ogino et al., 2008; Uchikawa et al.,
2004). Fig. 2A shows the VISTA plot of the 190 kb interval containing
Six1 and the neighboring Six6 and Six4 on mouse Chr 12 comparedTable 1
Summary of enhancer activities directed by the conserved sequencesa.
Conserved sequence
Location
Chick embryo (6–48 h.p.e)
mSix1-8 Trigeminal placode/ganglion
Otic placode
Otic vesicle/VIIIth ganglion
Epibranchial placodes/ganglia
Somites
mSix1-9 Trigeminal ganglion
VIIIth ganglion
Epibranchial placodes/ganglia
mSix1-10 Somites
mSix1-11 Cranial mesenchyme
mSix1-12 Otic placode
Otic vesicle/VIIIth ganglion
Epibranchial placodes/ganglia
Rathke’s pouch
Nephrogenic cord
mSix1-14 Rostral pre-placodal region
mSix1-17 Notochord
Mesoderm
Cranial ectoderm
mSix1-21 Olfactory placode/epithelium
Otic placode
Otic vesicle/VIIIth ganglion
Epibranchial placodes/ganglia
Rathke’s pouch
a Major enhancer activities of 16 CNSs at Six1 were assayed by chick electroporatio
showed enhancer activity in chick and one additional CNS, Six1-13 (5 transgenic em
transgenesis (E10.5). For Six1-14, the enhancer activity was also analyzed by Xenopuswith syntenic regions of human, opossum, chicken, Xenopus and ﬁve
teleost genomes. Sequence blocks that showed higher than 50%
identity over 100 bp both in mammals and in chicken or Xenopus
were deﬁned as CNSs. We focused on CNSs located in the 150-kb
region between the neighboring Six6 and Six4 gene exons. In our
previous study (Sato et al., 2010), one CNS (Six1-14) was identiﬁed as
an enhancer speciﬁc to the rostral PPR and early endoderm. Among
15 other CNSs ranged from 0.1 to 0.7 kb (Six1-8 to Six1-29), the
majority clustered in the 20-kb region ﬂanking Six1 exons (Fig. 2B),
which is reminiscent of the distribution of multiple independent
enhancers around the Sox2 exon (Uchikawa et al., 2003). It is
noteworthy that one CNS, Six1-17, overlapped with three transcribed
sequences (ESTs) located 30 to Six1 exons, AK035085, AK034831 and
AK142897, in which only AK142897 was in the same orientation with
Six1 transcripts, indicating that the region is transcribed from both
strands.CNSs enhancer activities in chick embryos
To examine the potential enhancer activities of the 15 CNSs
identiﬁed by comparative genomics, we isolated 15 CNSs from the
C57BL/6J mouse genomic DNA as 0.5 to 0.8 kb fragments, termed
mSix1-8 to mSix1-29, and constructed EGFP reporter plasmids.
Initially, the reporters were introduced into the entire epiblast of
chick embryos (HH4-4þ , gastrulae) by electroporation, cultured
on albumen-agar plate and enhancer activities were assessed as
EGFP expression. mSix1-24, a CNS closest to Six6 exons, showed
EGFP expression in the forebrain and the neural tube (data not
shown). Since Six1 is not expressed in the central nervous system
while the expression of Six6 is speciﬁc to the forebrain (Jean et al.,
1999), we excluded this CNS from further analysis. Among the
remaining 14 CNSs, seven CNSs showed EGFP expression in
speciﬁc subdomains in the Six1 expression domains in a 48-hr
culture period (mSix1-8, 9, 10, 11, 12, 17 and 21, Fig. 3A) whileReferences
Mouse embryo E10.5
Trigeminal placode/ganglion
VIIIth ganglion
Epibranchial placodes/ganglia
Trigeminal ganglion
VIIIth ganglion
Epibranchial placodes/ganglia
Somites
Cranial mesenchyme
Otic vesicle/VIIIth ganglion
Epibranchial placodes/ganglia
Rathke’s pouch
Nephrogenic cord
Rostral pre-placodal region Sato et al., 2010
Endoderm
Notochord
Olfactory placode/epithelium
Otic vesicle/VIIIth ganglion
Epibranchial placodes/ganglia
Pharyngeal pouch endoderm
Rathke’s pouch
n (examined at 6, 12, 24 and 48 h post-electroporation (h.p.e.)). Then, 8 CNSs that
bryos only showed variable lacZ expression patterns), were assayed by mouse
transgenesis (examined at St. 15 and St. 19) (Sato et al., 2010).
S. Sato et al. / Developmental Biology 368 (2012) 95–108102the remaining seven CNSs showed no EGFP expression. Two Six1
exons (the most conserved sequences in the 150-kb region
surveyed in our study) also did not show any enhancer activity
on its own (data not shown). We also conﬁrmed the enhancer
activities of all positive CNSs using multimerized (2x and/or 4x)
reporters by electroporation into chick embryos, since EGFP
expression levels of some CNSs were relatively low. Multimeriza-
tion signiﬁcantly augmented enhancer activities and allowed
earlier detection of EGFP in some cases, but the main expression
domains of EGFP were unaltered compared with the original
reporters. Also, all positive CNSs were assessed for enhancer
activity in the DRGs by electroporation into the HH9-10 neural
tube in ovo. The results are summarized in Fig. 3 and Table 1.
Enhancers for cranial placodes
Four CNSs (mSix1-8, 9, 12 and 21, Fig. 3A) activated EGFP
expression in the cranial placodes, each driving the expressionFig. 4. Enhancer activity of 8 CNSs in transgenic mouse embryos. (A–C) Enhancer activit
expression in the cranial ganglia (v and vii–x) and dorsal root ganglia (drg). Transverse
ganglion (v) and DRG (drg). (D, E) Enhancer activity of mSix1-9-hsp68-lacZpA. Whole m
ganglia (v, vii–x). (F–I) Enhancer activity of mSix1-12-hsp68-lacZpA. Whole mount em
ganglia (vii–x) and pharyngeal endoderm (pe). Another coronal section (H) showing
(I) showing expression in the nephrogenic cord (nc). (J–M) Enhancer activity of mSix1
showing expression in the olfactory placode (ol), otic vesicle (ov), cranial sensory gangli
activity of mSix1-10-hsp68-lacZpA. Whole mount embryo at E10.5 (N) and transverse
expression is localized in the myotome. (P, Q) Enhancer activity of mSix1-11-hsp68-la
(Q) showing expression in the cranial mesenchyme (cm). The result of chick embryo e
origin. (R, S) Enhancer activity of mSix1-17-hsp68-lacZpA. Whole mount embryo at E10
in the notochord (no), ﬂoor plate (fp), epibranchial ectoderm (ep) and pharyngeal pouc
panels C–G, I, J, R and S, particularly in E, lacZ expression is detected in cells located
expression pattern of reporter gene was observed in most of the CNSs but never in chick
hsp68 promoter or another part of the transgene backbone is responsible for the report
panels are lateral views. The planes of sections are indicated by yellow dotted lines in
epibranchial ectoderm, nc: nephrogenic cord, no: notochord, ol: olfactory placode, ov: o
vii, ix and x: epibranchial ganglia, viii: VIIIth ganglion. Scale bars: 1 mm (A, D, F, J, N, P, R
this ﬁgure legend, the reader is reffered to the web version of this article.)in a unique subset of placodes, except the lens placode, which is
negative for endogenous Six1 expression (Oliver et al., 1995).
mSix1-8 activated EGFP expression in the otic placode and the
ectoderm at the level of developing mid- to hindbrain at 24 h.p.e.
(Fig. 3B). To determine the identity of EGFP-positive cells at the mid-
to hindbrain level, immunohistochemical analyses for Pax3 (a marker
of ophthalmic trigeminal placode in chick) and HNK-1 antigen
(a marker of migrating neural crest) (Xu et al., 2008) were carried
out. As shown in Fig. 3C and D, EGFP was expressed in the ectodermal
cells and few ingressing cells, which were mostly Pax3-positive
(Fig. 3C) but distinct from migrating neural crest cells labeled by
HNK-1 antibody (Fig. 3D). These ﬁndings indicate that mSix1-8
activated EGFP expression in the trigeminal placode. At 48 h.p.e.,
EGFP expression was found in the Vth, VIIIth and epibranchial (VII, IX
and Xth) sensory ganglia and otic vesicle (Fig. 3F).
mSix1-9 showed a similar but weak EGFP expression only at
48 h.p.e. in the Vth and VIIIth ganglia and epibranchial ectoderm,
but not in the otic vesicle (Fig. 3H, I). mSix1-12 activated EGFPy of mSix1-8-tkintron-lacZpA-ins. Whole mount embryo at E10.5 (A) showing lacZ
sections at the head (B) and trunk (C) levels showing expression in the trigeminal
ount embryo at E10.5 (D) and coronal section (E) showing expression in the cranial
bryo at E10.5 (F) and coronal section (G) showing lacZ expression in the cranial
expression in the Rathke’s pouch (rp), and transverse section at the trunk level
-21-hsp68-lacZpA. Whole mount embryo at E10.5 (J) and coronal sections (K–M)
a (vii–x), epibranchial ectoderm/placodes, and Rathke’s pouch (rp). (N, O) Enhancer
section at the trunk level (O) showing expression in the somites (so). Strong lacZ
cZpA. Whole mount embryo at E10.5 (P) and transverse section at the head level
lectroporation strongly suggests that these mesenchymal cells are of mesodermal
.5 (R) and transverse section through the otic vesicle (S) showing EGFP expression
h endoderm (pe). Expression in the ﬂoor plate is limited to the anterior region. In
in the ventral portion of the hind brain and spinal cord. Since this characteristic
electroporation that used the tk promoter and EGFP reporter, we reasoned that the
er expression. In all panels of whole mount embryos, anterior is to the left and all
A, D, F, J, N, P, R. br: brain, cm: cranial mesenchyme, drg: dorsal root ganglia, ep:
tic vesicle, rp: Rathke’s pouch, so: somites, sc: spinal cord, v- trigeminal ganglion,
), 0.2 mm (B, C, E, G–I, K–M, O, Q, S). (For interpretation of the references to color in
S. Sato et al. / Developmental Biology 368 (2012) 95–108 103expression in the otic placode/vesicle and epibranchial ectoderm
at both 24 h.p.e. (Fig. 3J) and 48 h.p.e. (Fig. 3K). Sectioning of the
head of a 48 h-embryo showed EGFP expression in the Rathke’s
pouch (Fig. 3L). mSix1-21 activated EGFP expression in the
olfactory and otic placodes and epibranchial ectoderm at
24 h.p.e. (Fig. 3N) and the strong otic expression was still main-
tained at 48 h.p.e. (Fig. 3O, P). At that stage, EGFP expression also
appeared in the VIIIth ganglion (Fig. 3O), epibranchial ectoderm
(Fig. 3O, P) and Rathke’s pouch (Fig. 3R). In the olfactory region
(Fig. 3O, Q), EGFP expression was detected in the olfactory
placode/epithelium (Fig. 3Q). Interestingly, several cells in the
olfactory placode/epithelium and a cluster of cells in the
mesenchyme beneath the placode were strongly positive for EGFP
signals as were scattered cells adjacent to the forebrain (Fig. 3Q).
The EGFP expression pattern was fairly similar to the endoge-
neous expression pattern of chick Six1 (Fig. S1H, I) but was
different from that of mouse Six1 described previously (Chen
et al., 2009; Ikeda et al., 2007).
Enhancers for other structures
One of the CNSs with placode enhancer activity, mSix1-8,
activated EGFP expression in somites (Fig. 3E). Also, following
electroporation of the mSix1-8 reporter into the neural tube at
HH9-10, EGFP expression was detected in the DRG at 48 h.p.e (at
HH21, Fig. 3G). Other CNSs were negative for such activity.
Another CNS with placode enhancer activity, mSix1-12, directed
EGFP expression in the nephrogenic cord (Fig. 3M). In addition,
the following three enhancers activated transcription primarily in
mesodermal structures: Six1-10 activated EGFP expression in the
somite/myotome (Fig. 3S, T). mSix1-11 activated EGFP expression
in the cranial mesenchyme (Fig. 3U, V). Interestingly, the EGFP-
positive cells did not overlap with the HNK-1-positive neural
crest cells (Fig. 3W), indicating that mSix1-11 induced the
expression in the cranial mesoderm. mSix1-17 activated EGFP
expression strongly in the notochord, weakly in the surrounding
mesoderm (Fig. 3X, Y), and weakly in the cranial ectoderm and
the ﬂoor plate of the cervical neural tube (Fig. 3Z).
In summary, 7 out of 15 CNSs isolated from the mouse genome
exhibited speciﬁc enhancer activity in all placodes positive for
Six1 expression, DRG, and other non-ectodermal structures, such
as somites, cranial mesoderm, nephrogenic cord and notochord,
in chick embryos. Together with the previously identiﬁed enhan-
cer (mSix1-14), the combined enhancer activities of 8 CNSs cover
the major conserved expression domains of Six1.
Enhancer activities of CNSs in transgenic mouse embryos
To provide evidence that the enhancer activities detected in
the present study in the chick embryo reﬂect the endogenous
activity of each CNS (mSix1-8, 9, 10, 11, 12, 17 and 21, Fig. 3A) in
mouse embryos, we constructed transgenes with the reporter lacZ
gene and generated transgenic mouse embryos. The results were
summarized in Fig. 4 and Table 1.
Enhancers for cranial placodes
Four CNSs (mSix1-8, 9, 12 and 21) that activated EGFP expression
in the cranial placodes of chick embryos also activated lacZ expres-
sion in the same unique subsets of placodes and their derivatives in
E10.5 transgenic mouse embryos. The mSix1-8 reporter with ﬂanking
insulators derived from the chick b-globin locus (Recillas-Targa et al.,
2002) activated lacZ expression speciﬁcally in the Vth, VIIIth and
epibranchial sensory ganglia in all (5/5) transgenic embryos (Fig. 4A
and B). mSix1-9 also showed similar lacZ expression in the cranialganglia (2/4 transgenic embryos, Fig. 4D, E). mSix1-12 activated lacZ
expression in the otic vesicle, VIIIth and epibranchial sensory ganglia
(3/5 transgenic embryos, Fig. 4F, G) and the Rathke’s pouch (3/5
transgenic embryos, Fig. 4H). mSix1-21 activated lacZ expression in
the olfactory placode/epithelium (Fig. 4J, K and S2), otic vesicle
(Fig. 4J, L), the VIIIth and epibranchial sensory ganglia (3/5 transgenic
embryos, Fig. 4J, L), and the Rathke’s pouch (2/5 transgenic embryos,
Fig. 4M). In the epibranchial area, LacZ staining was not limited to the
thickened placodes but extended to the ﬂanking region composed of
ﬂat ectodermal cells (Fig. 4J, L).Enhancers for other structures
The mSix1-8 reporter activated lacZ expression in the DRG (5/5
transgenic embryos, Fig. 4A, C). In contrast to the result of chick
electroporation (Fig. 3E), somites were negative for lacZ expres-
sion (Fig. 4A). mSix1-12 activated lacZ expression in the nephro-
genic cord (2/5 transgenic embryos, Fig. 4I). Also, Six1-10
activated lacZ expression in myotomes (3/3 transgenic embryos,
Fig. 4N, O), mSix1-11 in the cranial mesenchyme (4/8 transgenic
embryos, Fig. 4P, Q) and mSix1-17 in the notochord (3/8 trans-
genic embryos, Fig. 4R, S). In some embryos, mSix1-10 (3/3
transgenic embryos) and mSix1-17 (3/8 transgenic embryos)
activated LacZ expression in the branchial region (Fig. 4N, R, S).
mSix1-21 activated LacZ expression in the pharyngeal pouch
endoderm (Fig. 4J and data not shown).
Therefore, all the 8 CNSs (including mSix1-14) initially identiﬁed
using the chicken electroporation system exhibited essentially the
same enhancer activities in the mouse, which collectively covered the
major Six1 expression domains. The enhancer activity of mSix1-14 in
the early endoderm, in which it was difﬁcult to introduce DNA in
chick embryos at HH4 in our hands, was identiﬁed by mouse
transgenesis (Sato et al., 2010). Also, while enhancer activity in the
epibranchial placode/ganglia of the cultured chick embryos was
difﬁcult to demonstrate due to the relatively underdeveloped phar-
yngeal arches, mSix1-8, 9, 12 and 21 exhibited enhancer activity in
the epibranchial sensory ganglia of transgenic mouse embryos.
Identiﬁcation of essential cis-elements for mSix1-21 enhancer activity
mSix1-21 is the most conserved CNS in the Six1 locus, based
on BLAST comparison of mouse sequences against chick and
Xenopus genomes. It was also identiﬁed in all teleost genomes
surveyed in the present study. Another characteristics of mSix1-
21 is that the enhancer activated reporter gene expression in the
largest number of placodes and placode-derived structures
among the identiﬁed Six1 enhancers (Figs. 3 and 4 and Table 1).
In addition, among the three enhancers that activated the expres-
sion in the otic placode/vesicle of chick embryos, mSix1-21
always yielded the strongest signal, suggesting that it is the
major conserved otic enhancer of Six1. Furthermore, mSix1-21
was the only identiﬁed enhancer that activated gene expression
in the olfactory placode/epithelium area. These ﬁndings prompted
us to examine the regulatory mechanisms of mSix1-21 enhancer
activity. For this purpose, we characterized the cis-elements
required for the activity of mSix1-21 in vivo.
Fig. 5A shows the alignment of the core conserved regions of
Six1-21 from four tetrapod species. Although the sequences are
highly conserved, initially we could only identify the binding sites
of the following transcription factors: Sox, Fox, Pax, Lef1/Tcf and
E-box-binding basic-helix-loop-helix (bHLH) protein. To address
the role of these sites, we introduced wild-type (mRFP1) and
mutated (EGFP) reporters into chick embryos and quantitated the
change in reporter gene expression in the otic vesicle at 48 h.p.e.
(Fig. 5Ba). As shown in Fig. 5Bb and Bc, the most dramatic
Fig. 5. Sequence and functional analysis of Six1-21, the Six1 placode enhancer. (A) Alignment of the core conserved regions of Six1-21 from Xenopus, chick, human and
mouse. Binding sites for Sox proteins (Sox, cyan shading), Gata proteins (Gata, yellow shading), Six proteins (Six, orange shading), Tcf/Lef1 proteins (Tcf/Lef1, magenta
shading), Pax proteins (red letters), Fox proteins (blue letters), and bHLH-binding E-box (Ebox, green shading). Numbers in brackets indicate numbers of conserved binding
sites of each category. (B) Mutation analysis of mSix1-21 in chick. ptkmRFP1-mSix1-21wt (wild-type reporter, red) was co-electroporated with ptkEGFP constructs (green):
mSix1-21wt (top, Ba), Sox1m (middle, Bb) and Six-12m (bottom, Bc) were examined at 48 h.p.e. Wild-type reporters mark the otic vesicle and epibranchial placode/ganglia
(ep), while Sox-1m and Six-12m mutations dramatically reduce EGFP levels. (Bd) Quantiﬁcation of the effect of various mutations on mSix1-21 enhancer activity. The
mean values of green (EGFP) and red (mRFP1) channels of an area that covers each otic vesicle were measured. The mean EGFP levels normalized to the mRFP1 levels are
shown relative to the value obtained from the wild-type reporter. The relative EGFP intensity detected in the otic vesicle that received reporters with various mutations
was signiﬁcantly lower (*po0.001) than that of embryos received wild-type reporter. Data are mean (þSD). 1: wild-type (n¼29), 2: Sox1m (n¼13), 3: Sox-12m (n¼13),
4: Six-12m (n¼14), 5: Pax-m2 (n¼14), 6: Pax-m1 (n¼17), 7: Lef1-m (n¼13), 8: Fox-12m (n¼9), 9: Ebox-12m (n¼12). (C) Known Six protein binding sequences. Six
protein binding sites from mouse Myog (Ohto et al., 1999), rat Atp1a1 (Kawakami et al., 1996), mouse Myc (Yu et al., 2006), mouse Ccnd1 (Yu et al., 2006), mouse Ezr (Yu
et al., 2006), mouse Sall1 (Chai et al., 2006) are aligned, and shown along the consensus binding sequence of Six-type homeodomains (GRTATCA) (Affolter et al., 2008;
Berger et al., 2008; Noyes et al., 2008). WebLogo (Crooks et al., 2004) of the aforementioned six Six protein binding sequences is shown at the bottom. The letter size is
proportional to the degree of nucleotide conservation. (D) Mutation analysis of mSix1-21 in mouse. Wild-type (mSix1-21-lacZ, Da) and mutated [(mSix1-21-Sox-1m-lacZ,
Db) and (mSix1-21-Six-12m-lacZ, Dc and Dd)] transgenes were used for transgenesis and lacZ expression was examined at E10.5. Embryos injected with the wild-type
transgene show lacZ expression speciﬁcally in the olfactory placode, otic vesicle and epibranchial placode/ganglia (3 embryos with speciﬁc lacZ expression/5 transgenic
embryos, Da). However, the expression is different in those carrying Sox-1m mutation: lacZ expression is reduced in the olfactory placode/epithelium (indicated by an
arrow) while it is maintained in otic/epibranchial area (4 embryos with altered lacZ expression/5 transgenic embryos, Db). In embryos carrying Six-12m mutation, lacZ
expression is severely reduced both in the olfactory and otic/epibranchial areas (4 embryos with reduced lacZ expression/5 transgenic embryos, Dc and Dd). All images
(chick and mouse) are lateral views, and anterior is to the left. Abbreviations as in Figs. 1, 3 and 4. Scale bars: 0.2 mm (Ba–Bc), 1 mm (D). (For interpretation of the
references to color in this ﬁgure legend, the reader is reffered to the web version of this article.)
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was noted in association with mutation of one (Sox-1m) or two
(Sox-12m) putative Sox-binding sites. Mutations of Pax (Pax-m2
and Pax-m1 mutations) and two Fox binding sites (Fox-12m) also
resulted in signiﬁcant reduction of the enhancer activity
(Fig. 5Bd). In contrast to the mutations of the aforementioned
binding sites, mutations of two E-boxes (Ebox-12m) and oneunique Lef1/Tcf binding site (Lef1-m) reduced the enhancer
activity only by about half (Fig. 5Bd).
Previous studies indicated that Six1 expression in the otic
vesicle is dependent on the presence of functional Six1 and Six4
(Grifone et al., 2005), indicating the importance of positive
autoregulatory mechanism. To explore the role of mSix1-21 in
this process, we searched for potential Six protein binding sites
S. Sato et al. / Developmental Biology 368 (2012) 95–108 105(TCAGGTNNC) predicted from known Six1/4/5 target genes listed
in Fig. 5C (Chai et al., 2006; Kawakami et al., 1996; Ohto et al.,
1999; Yu et al., 2006). As shown in Fig. 5Bc and Bd, Six-12m
mutation (disruption of two of the three predicted Six-binding
sites conserved in tetrapods) reduced the enhancer activity in the
otic vesicle. Single mutations (Six-1m and Six-2m) were also
analyzed, but they had only a marginal effect (data not shown).
To conﬁrm the importance of Sox- and Six-binding sites for the
mSix1-21 enhancer activity, we generated mouse embryos carry-
ing mutated transgenes. Fig. 5Da shows lacZ expression patterns
driven by the wild-type mSix1-21 enhancer at E10.5. Unexpect-
edly, mSix1-21-Sox-1m modiﬁed the expression pattern of lacZ
(4/5 transgenic embryos, Fig. 5Db). The lacZ expression in the
olfactory placode/epithelium was severely reduced although the
expression in the otic and epibranichial placodes/ganglia seemed
relatively preserved. In the case of mSix1-21-Six-12m, lacZ
expression was reduced both in the olfactory and otic/epibran-
chial areas (4/5 transgenic embryos, Fig. 5Dc, Dd) and ectopic
expression of lacZ was observed in all transgenic embryos.
Although it is difﬁcult to control the number of transgenes
integrated into the individual embryos during mouse transgen-
esis, and one cannot compare directly lacZ expression levels in
different embryos/transgenes (Fig. 5D), the result demonstrating
the importance of Sox- and Six-binding sites in normal mSix1-21
activity was consistent with the data obtained in chick and
conﬁrmed the importance of both sites in the regulation of
mSix1-21.Discussion
Multiple independent enhancers control Six1 expression
Six1 is expressed in a wide variety of organs derived from all
three germ layers and plays essential roles in organogenesis. The
present study demonstrated that eight CNSs, including one CNS
already described in a previous study (Sato et al., 2010) and seven
CNSs in this study, surrounding Six1 exons acted as tissue-speciﬁc
enhancers and each activated the transcription in a subset of Six1
expression domains (Table 1). Importantly, the major Six1 expres-
sion domains during development were covered by the sum of
the enhancer activities. In addition, all the eight CNSs clustered
within the 20-kb region surrounding Six1 exons (Figs. 2 and 3)
while another CNS (Six1-24) with enhancer function located next
to Six6 exons at about 100 kb downstream from the Six1 exons
activated transcription in the central nervous system, in which
Six6 (Jean et al., 1999) but not Six1 is expressed. Previous stud-
ies described enhancers for developmentally important genes,
such as Sox2 (Uchikawa et al., 2003), SCL (Gottgens et al., 2000),
Irx3/5/6 cluster (de la Calle-Mustienes et al., 2005), N-cadherin
(Matsumata et al., 2005) and Eya1 (Ishihara et al., 2008b), in the
DNA regions sandwiched between upstream and downstream
ﬂanking genes (exons). Our results indicate that the eight CNSs
identiﬁed in this study represent major evolutionarily conserved
enhancers responsible for the endogenous expression of Six1. It is
plausible, however, that sequences outside the 150-kb region or
coding sequences are also involved in the regulation of Six1.
Chick electroporation has been successfully used in the past to
identify enhancers of small number of genes (Ishihara et al., 2008b;
Izumi et al., 2007; Matsumata et al., 2005; Uchikawa et al., 2003). In
the present study, we provided another example showing the
effectiveness of using chick electroporation for systematic identiﬁca-
tion of conserved enhancers, as well as provided conﬁrmative data
with mouse transgenesis (Figs. 3 and 4, and Table 1). Admittedly, the
enhancer activities detected by chick electroporation were not always
reproduced in mouse transgenesis. mSix1-8 activated transcription insomites in chick embryos only and mSix1-21 activated transcription
in the olfactory placode area differently in chick and mouse embryos,
which could primarily reﬂect species differences (discussed below).
Thus, we advocate the use of chick embryo for the assessment of
enhancer activity of any DNA fragments that act from gastrulation
through early organogenesis stages in vertebrate embryos. The new
improved gene transfer technique that enables the introduction of
DNA into early endoderm (Voiculescu et al., 2008) should also
facilitate such studies.
Six1 enhancers as a new tool to understand development
The identiﬁcation of major Six1 enhancers led to the under-
standing of the regulatory mechanism that controls Six1 expres-
sion in tetrapod embryos. (1) Six1 is regulated by at least eight
discrete enhancers and each of which activates transcription in a
unique subset of Six1 expression domains. (2) During sensory
organogenesis, Six1 expression is controlled differently in the PPR
and its derivatives, i.e., Six1-14 is a single characterized enhancer
involved in the expression in the PPR (none of the seven
enhancers described here are expressed early on in the PPR)
while there are four placodal enhancers with distinct activities.
(3) The expression of Six1 in each structure [e.g., PPR (Six1-14),
early endoderm (Six1-14), olfactory placode (Six1-21), trigeminal
placode/ganglia (Six1-8), DRG (Six1-8), cranial mesoderm (Six1-
11), somites (Six1-10), notochord (Six1-17) and nephrogenic cord
(Six1-12)] is driven by a single major enhancer. The above
information should help us identify upstream signals and tran-
scription factors that directly control Six1 expression during
various organogenesis by focusing on the response of enhancers
of less than 1 kb. Indeed, we were able to identify promising
candidates that regulate Six1 expression in the PPR (Sato et al.,
2010) and the potential regulatory mechanism in the olfactory/
otic/epibranchial placodes (Fig. 5 and see below). Further analysis
should enhance our understanding of the etiology of BOR and
related syndromes: mutations that affect some of the identiﬁed
Six1 enhancers might be causative for those disorders as
described previously for mutations of SHH (Lettice et al., 2003),
RET (Emison et al., 2005) and MYC (Wasserman et al., 2010).
Recently, the Six1-12 enhancer was identiﬁed as a Six1 cardiac
enhancer and its analysis stressed the role of Six1 in postnatal
cardiac homeostasis (Delgado-Olguı´n et al., 2012) although Six1-
12 variants that affect its integrity are yet to be identiﬁed. As to
the reasons why we failed to identify Six1-12 as the cardiac
enhancer are as follows: (1) we could not introduce DNA into the
cardiac mesoderm by electroporation in chick embryos, and (2)
only one embryo out of ﬁve transgenic mouse embryos showed
any cardiac lacZ expression (data not shown). So a weak cardiac
enhancer activity was detected in retrospect but the result was
not included in Fig. 4 or Table 1.
Another important application of the identiﬁed Six1 enhancers
would be to use them as switches to control the expression of
desired genes in speciﬁc tissues in transgenic mouse lines,
particularly in the sensory placodes. Also, the identiﬁed enhan-
cers would be ideal to create tissue-speciﬁc Six1 knockout mouse
lines in order to determine the precise role of Six1 in a given germ
layer or a cell type.
Evolution of Six1 enhancers in vertebrates
Identiﬁcation of conserved Six1 enhancers allow us to spec-
ulate on the origin and evolution of the expression pattern of Six1.
We have shown that four CNSs (Six1-8, 10, 12 and 21) are
conserved between tetrapods and teleosts. What about more
basal vertebrates or invertebrate chordates? The presence of eight
Six1 enhancers in the lamprey Petromyzon marinus is unclear due
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to the eight enhancers were found in the ascidian Ciona intesti-
nalis (data not shown). In addition, related sequences were
neither found around Six2 (Six1 paralog), Eya1/2 (genes often co-
expressed with Six1) (Ishihara et al., 2008a) nor any other part of
the mouse genome (data not shown). Thus, the most parsimo-
nious scenario regarding the evolution of eight conserved Six1
enhancers identiﬁed in our study would be as follows: (1) The
common ancestors of agnathans (lampreys and hagﬁshes) and
gnathostomes may not have possessed any of the eight conserved
CNSs as deduced from the recently described model for the
expansion of vertebrate speciﬁc conserved non-coding sequences
(McEwen et al., 2009). (2) At least four Six1 enhancers, Six1-8, 10,
12 and 21, have been (acquired and) present before the diver-
gence of teleosts and tetrapods. It is noteworthy that the com-
bined activities of the above four enhancers is sufﬁcient to drive
transcription in all Six1-positive placodes, somites and nephro-
genic cord. Six1-14, the tetrapod PPR/endoderm enhancer, may
also have been present although it was difﬁcult to detect
sequences overtly similar to Six1-14 in extant teleost genomes
(see Fig. 2 and discussion in Sato et al., 2010). (3) Acquisition of
the remaining three enhancers, Six1-9, 11, and 17 occurred in the
tetrapod lineage after the teleost-tetrapod divergence. The fact
that Six1 expression has not been described in tissues such as
cranial mesoderm and notochord in zebraﬁsh (Bessarab et al.,
2004, 2008) is consistent with this. To test the validity of the
above scenario and to investigate the origins of vertebrate Six1
enhancers and structure such as PPR and placodes, we need to
understand the regulatory mechanism of Six1 expression in
agnathans and basal chordates (Bassham and Postlethwait,
2005; Mazet et al., 2005; Schlosser, 2008).
Importance of positive autoregulation for Six1 expression in placodes
Functional analysis of the major olfactory/otic/epibranchial
placode enhancer, mSix1-21, indicates that the enhancer inte-
grates a variety of inputs from Sox, Pax, Fox, Six, Wnt/Lef1 and
bHLH proteins. The fact may reﬂect the importance of Six1 as one
of the core transcription factors governing otic development
(Ozaki et al., 2004; Zou et al., 2004). Among the aforementioned
factors, particularly important are Sox and Six proteins (Figs. 3–5).
Sox2 and Sox3 are expressed in all placodes except trigeminal
placode (Abu-Elmagd et al., 2001; Schlosser, 2006; Uchikawa
et al., 2003). Also, Sox9 and Sox10 are expressed in the otic
placode (Schlosser, 2006). In chick electroporation, mutation of
Sox-binding site resulted in severe reduction in the reporter gene
expression in the otic vesicle (Fig. 5B) and mouse transgenesis
revealed that the mutation has a more profound effect on the
expression in the olfactory placode (Fig. 5D). The involvement of
Sox protein on Six1 expression in the olfactory placode is
consistent with the ﬁnding of normal Sox2 expression in the
placode of Six1 knockout mouse embryos (Ikeda et al., 2007).
With regard to the involvement of Six proteins in the regula-
tion of Six1 expression in the sensory placodes, Six1, Six4, Six3 and
Six6 are expressed in the olfactory placode, and Six1 and Six4 are
also expressed in the trigeminal placode, otic placode and
epibranchial placodes (Jean et al., 1999; Laclef et al., 2003b;
Oliver et al., 1995; Ozaki et al., 2001). Thus, it is likely that
Six1-21 is positively regulated by Six proteins in the olfactory and
otic/epibranchial placodes, and this is the molecular basis for the
severe reduction of Six1 expression in the otic placode of Six1/4
double knockout embryos (Grifone et al., 2005). Given that Six1
and Six4 are present in the PPR before the start of placode
speciﬁcation, it is not clear whether Six proteins are required
for the initiation of placode-speciﬁc upregulation of Six1 or
whether they are required for the maintenance of Six1 in the oticvesicle. While it is also possible that Six proteins are involved
both in the initiation and maintenance, this is the ﬁrst report on
the potential molecular mechanism of positive autoregulation of
Six1 expression during development.
Conserved and diverged expression patterns of Six1 in vertebrates
The present study showed different Six1 expression patterns in
chick and mouse in the olfactory placode area (Fig. 1). In chick,
Six1 is strongly expressed in a cluster of cells located underneath
the olfactory placode that perfectly match the description of the
ﬁrst-born cells that migrate out from the placode and express
N-CAM, HuC/D, Lhx2, Ngn1, Gap43 (Croucher and Tickle, 1989;
Drapkin and Silverman, 1999; Fornaro et al., 2001, 2003; Maier
and Gunhaga, 2009; Mendoza et al., 1982) and Eya2 (Ishihara
et al., 2008a). While the function of these early-delaminating
neurons remains unclear, it has been suggested to perforate the
basal lamina to create openings and the scaffold later utilized by
the emerging olfactory axons and to migrate towards the fore-
brain (Croucher and Tickle, 1989; Drapkin and Silverman, 1999;
Fornaro et al., 2001, 2003; Maier and Gunhaga, 2009; Mendoza
et al., 1982). In mammals, a group of cells known as the pioneer
neurons is produced during the development of olfactory epithe-
lium and are considered to play similar roles (Bystron et al., 2006;
Ikeda et al., 2007). In mouse, Six1 expression is initiated in the
olfactory placode but rapidly downregulated in pioneer neurons
that emigrate outside the placode while the expression of mar-
kers, such as HuC/D, N-CAM, Gap43, SCG10, Ebf1 and Phd1, persists
in migrating pioneer neurons (Bystron et al., 2006; Ikeda et al.,
2007). Given that a single conserved enhancer (Six1-21) directs
Six1 expression in the olfactory area both in mouse and chick
(Figs. 2–5, S2), how can we explain this difference? There are two
potential explanations: (1) differences in the enhancer activity
itself deﬁned by the number, order and the afﬁnity of various
TFBSs, and (2) differences in the cellular environment, i.e.,
repertoire of trans-acting factors present in the olfactory pla-
code/epithelium lineage cells. We have shown in chick embryos
that EGFP driven by Six1-21 from mouse appeared more intense
in a cluster of cells subjacent to the olfactory placode than in the
epithelial cells comprising the placode (Fig. 3). On the other hand,
in mouse embryos, the same mouse enhancer activated transcrip-
tion in the thickened placode but not in the cells that emigrated
from the placode (Fig. 4 and S2). Thus, mouse Six1-21 activates
transcription in a pattern that closely matches the endogeneous
expression pattern of chick Six1 in chick and in a pattern that
closely matches that of mouse Six1 in mouse, pointing to the
difference in the cellular environment as the primary cause. The
result also suggests that the function of Six1 may not be con-
served during olfactory development between chick and mouse,
suggesting evolutionary changes in the olfactory developmental
program.Conclusions
The present study identiﬁed seven discrete enhancers that
collectively cover the major Six1 expression domains including
cranial placodes. Together with the previously identiﬁed PPR/
endoderm-speciﬁc enhancer, these represent major evolutionarily
conserved enhancers responsible for the complex expression
pattern of Six1 in tetrapods. Mutational analysis of the most
conserved placode-speciﬁc enhancer (Six1-21) demonstrated the
involvement of several transcription factors in the regulation of
this enhancer and the molecular basis of positive autoregulation
of Six1 expression in the otic/epibranchial placode area. The
results conﬁrmed that chick electroporation is a robust means
S. Sato et al. / Developmental Biology 368 (2012) 95–108 107to decipher regulatory information stored in the vertebrate
genomes, and the identiﬁed enhancers provide useful tools to
understand the mechanism of Six1 regulation and to manipulate
gene expression during development.Acknowledgments
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